Claims for Patent: 6,608,203

Summary for Patent: 6,608,203

Title:	Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
Abstract:	This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits comprising such compounds.
Inventor(s):	Cameron; Kimberly O. (East Lyme, CT), Chesworth; Richard (Mystic, CT), DaSilva-Jardine; Paul A. (Providence, RI), Day; Robert F. (Groton, CT), Lefker; Bruce A. (Gales Ferry, CT), Zawistoski; Michael P. (West Warwick, RI)
Assignee:	Pfizer Inc. (New York, NY)
Application Number:	09/745,396
Patent Claims:	1. A compound of the formula: ##STR18## wherein: A.sup.1 is hydrogen, hydroxy, (C.sub.1 -C.sub.4)alkoxy, or (C.sub.1 -C.sub.4)alkanoyloxy, said (C.sub.1 -C.sub.4)alkoxy or said (C.sub.1 -C.sub.4)alkanoyloxy optionally substituted by hydroxy, halo, di(C.sub.1 -C.sub.4 alkyl)amino or a partially saturated, fully saturated, or fully unsaturated five to twelve membered ring optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; A.sup.2, A.sup.3, and A.sup.4 are independently selected from hydrogen, hydroxy, (C.sub.1 -C.sub.4)alkoxy, and halo; R.sup.1 is (C.sub.1 -C.sub.7)alkyl; adamantyl; a partially saturated, fully saturated, or fully unsaturated three to twelve membered ring optionally comprising one to four heteroatoms selected independently from oxygen, sulfur, and nitrogen; a bicyclic ring consisting of two fused independently partially saturated, fully saturated, or fully unsaturated five to six membered rings, said bicyclic ring optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; or a bicyclic ring system consisting of two rings joined by a covalent bond, said rings being independently partially saturated, fully saturated, or fully unsaturated three to eight membered rings, said bicyclic ring system optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; wherein each of the above R.sup.1 groups is optionally substituted with one to seven fluoro, or optionally substituted with one to three substituents independently selected from Group A, wherein Group A consists of hydroxy, chloro, bromo, iodo, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy, (C.sub.3 -C.sub.8)cycloalkyl, R.sup.3 --(C.sub.1 -C.sub.4)alkoxy, (C.sub.2 -C.sub.4)alkenyl-COOR.sup.7, (C.sub.0 -C.sub.4)alkyl-COOR.sup.7, (C.sub.1 -C.sub.4)alkanoyloxy-(C.sub.2 -C.sub.4)alkenyl, (C.sub.2 -C.sub.4)alkenyl-CONR.sup.4 R.sup.5, (C.sub.0 -C.sub.4)alkyl-CONR.sup.4 R.sup.5, (C.sub.0 -C.sub.4)alkyl-NR.sup.4 R.sup.5, OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9, propyl-R.sup.8 R.sup.9, and SO.sub.2 --R.sup.6 ; X is (CH.sub.2).sub.n wherein n is 1, 2, or 3, (C.sub.0 -C.sub.1)alkylene-phenylene-(C.sub.0 -C.sub.1)alkylene, CO.sub.2, (C.sub.0 -C.sub.3)alkylene-CO--(C.sub.0 -C.sub.3)alkylene, or (C.sub.0 -C.sub.4)alkylene-SO.sub.2 --(C.sub.0 -C.sub.4)alkylene; R.sup.2 is (C.sub.1 -C.sub.9)alkyl; (C.sub.2 -C.sub.4)alkenyl; benzhydryl; a partially saturated, fully saturated, or fully unsaturated three to eight membered ring optionally comprising one to four heteroatoms selected independently from oxygen, sulfur, and nitrogen; a bicyclic ring consisting of two fused independently partially saturated, fully saturated, or fully unsaturated five to six membered rings, said bicyclic ring optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; or a bicyclic ring system consisting of two rings joined by a covalent bond, said rings being independently partially saturated, fully saturated, or fully unsaturated three to eight membered rings, and said bicyclic ring system optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; wherein said (C.sub.1 -C.sub.9)alkyl is optionally substituted with one to seven fluoro, or optionally substituted with one to three substituents independently selected from Group B, wherein Group B consists of chloro, (C.sub.1 -C.sub.4)alkoxy, amino, and (C.sub.1 -C.sub.4)alkylcarbonyl; wherein said (C.sub.2 -C.sub.4)alkenyl is optionally substituted with one to three substituents independently selected from Group C, wherein Group C consists of halo, (C.sub.1 -C.sub.4)alkoxy, amino, and (C.sub.1 -C.sub.4)alkylcarbonyl; and wherein said benzhydryl, said three to eight membered ring, said bicyclic ring, and said bicyclic ring system are each optionally substituted with one to three substituents independently selected from Group D, wherein Group D consists of halo, hydroxy, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy, imidazolyl, amino, (C.sub.1 -C.sub.4)alkylcarbonylamino, and (C.sub.1 -C.sub.4)alkylcarbonyl; R.sup.3 at each occurrence is independently pyrrolidino, piperidino, morpholino, or dimethylamino; R.sup.4 and R.sup.5 at each occurrence are independently hydrogen, (C.sub.1 -C.sub.4)alkyl, hydroxy(C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy-(C.sub.1 -C.sub.4)alkylene, or (C.sub.3 -C.sub.8)cycloalkyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached are pyrrolidino, piperidino, morpholino, or hexamethyleneimino; R.sup.6 at each occurrence is independently imidazolyl, thienyl, benzathienyl, or isoxazyl, said imidazolyl, thienyl, benzathienyl, or isoxazyl each optionally substituted with one to three substituents independently selected from (C.sub.1 -C.sub.4)alkyl; R.sup.7 at each occurrence is independently hydrogen or (C.sub.1 -C.sub.4)alkyl; R.sup.8 and R.sup.9 are independently methyl or ethyl, or R.sup.8 and R.sup.9 taken together with the nitrogen atom to which they are attached are pyrrolidino, piperidino, morpholino, or hexamethyleneimino; and p is 0, 1, or 2; with the proviso that when X is (CH.sub.2).sub.2 or (CH.sub.2).sub.3, p is 0, and R.sup.1 is phenyl or phenyl substituted with one chloro, fluoro, bromo, hydroxy, methoxy, pyrrolidinoethoxy, piperidinoethoxy, or morpholinoethoxy substituent, then R.sup.2 is not phenyl, methoxyphenyl, tert-butyl, or cyclopentyl; and when X is CH.sub.2, (CH.sub.2).sub.2, COCH.sub.2, or CH.sub.2 CO, A.sup.1 is hydrogen, and R.sup.1 is phenyl, then R.sup.2 is not phenyl. 2. A compound of claim 1 wherein: A.sup.1 is hydroxy; A.sup.2, A.sup.3, and A.sup.4 are hydrogen; and p is 0. 3. A compound of claim 1 wherein R.sup.1 is (C.sub.1 -C.sub.4)alkyl, adamantyl, naphthyl, or a partially saturated, fully saturated, or fully unsaturated five to six membered ring optionally comprising one to two heteroatoms selected independently from oxygen, sulfur, and nitrogen; wherein each of said R.sup.1 groups is optionally substituted with one to seven fluoro, or optionally substituted with one to three substituents independently selected from Group A. 4. A compound of claim 3 wherein R.sup.1 is phenyl, cyclohexyl, pyridyl, thienyl, isopropyl, or adamantyl; wherein each of said R.sup.1 groups is optionally substituted with one to seven fluoro, or optionally substituted with one to three substituents independently selected from Group A. 5. A compound of claim 4 wherein R.sup.1 is phenyl or cyclohexyl; wherein each of said R.sup.1 groups is optionally substituted with one to seven fluoro, or optionally substituted with one to three substituents independently selected from Group A. 6. A compound of claim 3 wherein each of said R.sup.1 groups is optionally substituted with one to three bromo, chloro, fluoro or iodo, or optionally substituted with one substituent selected from hydroxy, (C.sub.1 -C.sub.2)alkoxy, pyrrolidino-(C.sub.1 -C.sub.4)alkoxy, dimethylamino, (C.sub.2 -C.sub.4)alkenyl-COOR.sup.7, COOR.sup.7, (C.sub.2 -C.sub.4)alkenyl-CONR.sup.4 R.sup.5 or SO.sub.2 --R.sup.6 ; R.sup.4 and R.sup.5 are independently hydrogen, (C.sub.1 -C.sub.4)alkyl, hydroxy(C.sub.1 -C.sub.4)alkyl, --(CH.sub.2 CH.sub.2 --O--CH.sub.3), or (C.sub.5 -C.sub.6)cycloalkyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached are piperidino or morpholino; and R.sup.6 is imidazolyl optionally substituted with one to three substituents independently selected from (C.sub.1 -C.sub.4)alkyl. 7. A compound of claim 6 wherein each of said R.sup.1 groups is optionally substituted with one to three fluoro, or optionally substituted with one substituent selected from iodo, chloro, bromo, hydroxy, methoxy, pyrrolidino-ethoxy, dimethylamino, COOR.sup.7 or ethenyl-CONR.sup.4 R.sup.5 ; R.sup.4 and R.sup.5 are each methyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached are piperidino or morpholino; and R.sup.7 is hydrogen or methyl. 8. A compound of claim 7 wherein each of said R.sup.1 groups is optionally substituted with one hydroxy or pyrrolidino-ethoxy. 9. A compound of claim 1 wherein X is CH.sub.2, CH.sub.2 -phenylene, CO.sub.2, CO--(C.sub.0 -C.sub.2)alkylene, or SO.sub.2 --(C.sub.0 -C.sub.2)alkylene. 10. A compound of claim 1 wherein X is CO or SO.sub.2. 11. A compound of claim 1 wherein R.sup.2 is (C.sub.1 -C.sub.7)alkyl; propenyl; a partially saturated, fully saturated, or fully unsaturated five to seven membered ring optionally comprising one to two heteroatoms selected independently from oxygen, sulfur, and nitrogen; a bicyclic ring consisting of two fused independently partially saturated, fully saturated, or fully unsaturated five to six membered rings, said bicyclic ring optionally comprising one to two oxygen atoms; or biphenyl; wherein said (C.sub.1 -C.sub.7)alkyl is optionally substituted with one to seven fluoro, or optionally substituted with one to three substituents independently selected from Group B; wherein said propenyl is optionally substituted with one to three substituents independently selected from Group C; and wherein each of said five to seven membered ring, said bicyclic ring, and said biphenyl is optionally substituted with one to three substituents independently selected from Group D. 12. A compound of claim 11 wherein R.sup.2 is methyl, t-butyl, phenyl, cyclohexyl, isoxazolyl, tetrahydropyranyl, naphthyl, or benzodioxolyl; wherein each of said methyl or t-butyl is optionally substituted with one to seven fluoro, or optionally substituted with one to three substituents independently selected from Group B; and wherein each of said phenyl, cyclohexyl, isoxazolyl, tetrahydropyranyl, naphthyl, or benzodioxolyl is optionally substituted with one to three substituents independently selected from Group D. 13. A compound of claim 12 wherein R.sup.2 is trifluoromethyl or phenyl; wherein said phenyl is optionally substituted with one to three substituents independently selected from Group D. 14. A compound of claim 11 wherein each of said (C.sub.1 -C.sub.7)alkyl and said propenyl in the definition of R.sup.2 is optionally substituted with one to three fluoro, or optionally substituted with one to two substituents independently selected from amino and methylcarbonyl; and wherein each of said five to seven membered ring, said bicyclic ring, and said biphenyl in the definition of R.sup.2 is optionally substituted with one to three fluoro, or optionally substituted with one to two substituents independently selected from hydroxy, (C.sub.1 -C.sub.3)alkyl, amino, and methylcarbonyl. 15. A compound of claim 1 wherein: A.sup.1 is hydroxy; A.sup.2, A.sup.3, and A.sup.4 are hydrogen; p is 0; R.sup.1 is phenyl, cyclohexyl, pyridyl, thienyl, isopropyl, or adamantyl; wherein each of said R.sup.1 groups is optionally substituted with one to three fluoro, or optionally substituted with one substituent selected from iodo, chloro, bromo, hydroxy, methoxy, pyrrolidino-ethoxy, dimethylamino, COOR.sup.7 or ethenyl-CONR.sup.4 R.sup.5 ; X is CH.sub.2, CH.sub.2 -phenylene, CO.sub.2, CO--(C.sub.0 -C.sub.2)alkylene, or SO.sub.2 --(C.sub.0 -C.sub.2)alkylene; and R.sup.2 is methyl, t-butyl, phenyl, cyclohexyl, isoxazoyl, tetrahydropyranyl, naphthyl, or benzodioxolyl; wherein each of said methyl or t-butyl is optionally substituted with one to three fluoro, or optionally substituted with one to two substituents independently selected from amino and methylcarbonyl; and wherein each of said phenyl, cyclohexyl, isoxazolyl, tetrahydropyranyl, naphthyl, or benxodiozolyl is optionally sutstituted with one to three fluoro, or optionally substituted with one to two substituents independently selected from hydroxy, (C.sub.1 -C.sub.3)alkyl, amino, and methylcarbonyl; R.sup.4 R.sup.5 are each methyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached are piperidino or morpholino; and R.sup.7 is hydrogen or methyl. 16. A compound of claim 15 wherein R.sup.1 is phenyl or cyclohexyl, wherein each of said phenyl or said cyclohexyl is optionally substituted with one to three fluoro, or optionally substituted with one substituent selected from iodo, chloro, bromo hydroxy, methoxy, pyrrolidino-ethoxy, dimethylamino, COOR.sup.7 or ethenyl-CONR.sup.4 R.sup.5 ; R.sup.4 and R.sup.5 are each methyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached are piperidino or morpholino; and R.sup.7 is hydrogen or methyl. 17. A compound of claim 15 wherein said phenyl or said cyclohexyl in the definition of R.sup.1 is optionally substituted with one hydroxy or pyrrolidino-ethoxy. 18. A compound of claim 15 wherein X is CO or SO.sub.2. 19. A compound of claim 15 wherein R.sup.2 is trifluoromethyl or phenyl, wherein said phenyl is optionally substituted with one to three fluoro, or optionally substituted with one to two substituents independently selected from hydroxy, (C.sub.1 -C.sub.3)alkyl, amino, and methylcarbonyl. 20. A compound of claim 15 wherein: R.sup.1 is phenyl or cyclohexyl, said phenyl or said cyclohexyl each optionally substituted with one hydroxy or pyrrolidino-ethoxy; X is CO or SO.sub.2 ; and R.sup.2 is trifluoromethyl or phenyl; wherein said phenyl is optionally substituted with one to three fluoro, or optionally substituted with one to two substituents independently selected from hydroxy, (C.sub.1 -C.sub.3)alkyl, amino, and methylcarbonyl. 21. A compound of claim 15 wherein said compound is 1-(4-hydroxy-phenyl)-2-phenyl-1,2,3,4-tetrahydroisoquinolin-6-ol, having the structure ##STR19## 3-[4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydroisoquinolin-1-yl)-phenyl]-1-pipe ridin-1-yl-propenone, having the structure ##STR20## 3-[4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydroisoquinolin-1-yl)-phenyl]-1-morp holin-4-yl-propenone, having the structure ##STR21## 3-[4-(6-hydroxy-2-phenyl-1,2,3,4-tetrahydroisoquinolin-1-yl)-phenyl]-N,N-di methyl-acrylamide, having the structure ##STR22## 22. A compound of claim 15 wherein said compound is 2-benzyl-1-[4-(2-pyrrolidin-1-yl-ethoxy)phenyl]-1,2,3,4-tetrahydroisoquino lin-6-ol, having the structure ##STR23## 23. A compound of claim 15 wherein said compound is 2,2,2-trifluoro-1-[6-hydroxy-1-(4-hydroxyphenyl)-3,4-dihydro-1H-isoquinoli n-2-yl]-ethanone, having the structure ##STR24## 24. A compound of claim 23 wherein said compound is 2,2,2-trifluoro-1-[6-hydroxy-1(R)-(4-hydroxyphenyl)-3,4-dihydro-1H-isoquin olin-2-yl]-ethanone, having the structure ##STR25## 25. A compound of claim 15 wherein said compound is 2-benzenesulfonyl-1-[4-(2-pyrrolidin-1yl-ethoxy)phenyl]-1,2,3,4-tetrahydro isoquinolin-6-ol, having the structure ##STR26## 2-(4-isopropylbenzenesulfonyl)1-[4-(2-pyrrolidin-1-yl-ethoxy)phenyl]-1,2,3, 4-tetrahydroisoquinolin-6-ol, having the structure ##STR27## 26. A compound of claim 1 wherein said compound is of formula (I): ##STR28## wherein: A.sup.1 is hydroxy, (C.sub.1 -C.sub.4)alkoxy, (C.sub.1 -C.sub.4)alkanoyloxy, or pyrrolidino-ethoxy; A.sup.2, A.sup.3, and A.sup.4 are hydrogen; p is 0 or 1; R.sup.1 is (C.sub.1 -C.sub.4)alkyl, (C.sub.4 -C.sub.7)cycloalkyl, adamantyl, phenyl, pyridyl, or thienyl, wherein each of said phenyl, pyridyl, or thienyl groups is optionally substituted with one to three fluoro, or optionally substituted with one substituent selected from iodo, chloro, bromo, hydroxy, methoxy, dimethylamino, OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9, COOR.sup.7, ethenyl-COOR.sup.7 or ethenyl-CONR.sup.4 R.sup.5 ; X is CH.sub.2, CH.sub.2 -phenylene, CO.sub.2, CO--(C.sub.0 -C.sub.2)alkylene, or SO.sub.2 --(C.sub.0 -C.sub.2)alkylene; R.sup.2 is (C.sub.1 -C.sub.7)alkyl, phenyl, benzyl, thienyl, (C.sub.5 -C.sub.7)cycloalkyl, isoxazolyl, imidazolyl, tetrahydropyranyl, naphthyl, or benzodioxolyl, wherein said (C.sub.1 -C.sub.7)alkyl is optionally substituted with one to three fluoro, or optionally substituted with one to two substituents independently selected from amino and methylcarbonyl, and wherein each of said phenyl, thienyl, (C.sub.5 -C.sub.7)cycloalkyl, isoxazolyl, tetrahydropyranyl, naphthyl, and benzodioxolyl is optionally substituted with one to three fluoro, or optionally substituted with one to two substituents independently selected from hydroxy, methoxy, (C.sub.1 -C.sub.3)alkyl, amino, and methylcarbonyl; and R.sup.4 and R.sup.5 are each methyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached are pyrrolidino, piperidino, hexamethyleneimino, or morpholino. 27. A compound of claim 26 wherein: p is 0; X is SO.sub.2 ; R.sup.1 is (C.sub.1 -C.sub.4)alkyl, (C.sub.4 -C.sub.7)cycloalkyl, adamantyl, phenyl, pyridyl, or thienyl, wherein each of said phenyl, pyridyl, or thienyl groups is optionally substituted with one to three fluoro, or with one substituent selected from iodo, chloro, bromo, hydroxy, methoxy, dimethylamino, OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9, COOR.sup.7 or ethenyl-CONR.sup.4 R.sup.5 ; R.sup.2 is phenyl, benzyl, napthyl, isoxazoyl, (C.sub.5 -C.sub.7)cycloalkyl, or (C.sub.1 -C.sub.4)alkyl, wherein each of said phenyl, benzyl, napthyl, and isoxazoyl is optionally substituted with one to two (C.sub.1 -C.sub.3)alkyl groups; and R.sup.4 and R.sup.5 are each methyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached are pyrrolidino, piperidino, hexamethyleneimino, or morpholino. 28. A compound of claim 27 wherein R.sup.1 is phenyl or thienyl, said phenyl or thienyl each optionally substituted with one to three fluoro or with one OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9. 29. A compound of claim 29 wherein: p is 0; X is CO; R.sup.1 is (C.sub.1 -C.sub.4)alkyl, (C.sub.4 -C.sub.7)cycloalkyl, adamantyl, phenyl, pyridyl, or thienyl, wherein each of said phenyl, pyridyl, or thienyl groups is optionally substituted with one to three fluoro, or optionally substituted with one substituent selected from iodo, chloro, bromo, hydroxy, methoxy, dimethylamino, OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9, COOR.sup.7, or ethenyl-CONR.sup.4 R.sup.5 wherein R.sup.4 and R.sup.5 are both methyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached form pyrrolidino, piperidino, hexamethyleneimino, or morpholino; and R.sup.2 is (C.sub.5 -C.sub.7)cycloalkyl, (C.sub.3 -C.sub.7)alkyl, napthyl, or trifluoromethyl, wherein said (C.sub.3 -C.sub.7)alkyl is optionally substituted with one to three fluoro. 30. A compound of claim 29 wherein R.sup.1 is phenyl or thienyl, said phenyl or thienyl each optionally substituted with one to three fluoro or with one OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9. 31. A compound of claim 26 wherein: p is 0; X is CH.sub.2 ; R.sup.1 is (C.sub.1 -C.sub.4)alkyl, (C.sub.4 -C.sub.7)cycloalkyl, adamantyl, phenyl, pyridyl, or thienyl, wherein each of said phenyl, pyridyl, or thienyl groups is optionally substituted with one to three fluoro, or with one substituent selected from iodo, chloro, bromo, hydroxy, methoxy, dimethylamino, OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9, COOR.sup.7, or ethenyl-CONR.sup.4 R.sup.5 wherein R.sup.4 and R.sup.5 are both methyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached form pyrrolidino, piperidino, hexamethyleneimino, or morpholino; and R.sup.2 is phenyl, thienyl, or benzodioxolyl, said phenyl, thienyl, or benzodioxolyl each optionally substituted with one to three fluoro or one imidazoyl group. 32. A compound of claim 31 wherein R.sup.1 is phenyl or thienyl, said phenyl or thienyl each optionally substituted with one to three fluoro or with one OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9. 33. A compound of claim 26 wherein: p is 0; X is CO.sub.2 ; R.sup.1 is (C.sub.1 -C.sub.4)alkyl, (C.sub.4 -C.sub.7)cycloalkyl, adamantyl, phenyl, pyridyl, or thienyl, wherein each of said phenyl, pyridyl, or thienyl groups is optionally substituted with one to three fluoro, or with one substituent selected from iodo, chloro, bromo, hydroxy, methoxy, dimethylamino, OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9, COOR.sup.7, or ethenyl-CONR.sup.4 R.sup.5 wherein R.sup.4 and R.sup.5 are both methyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached form pyrrolidino, piperidino, hexamethyleneimino, or morpholino; and R.sup.2 is phenyl or (C.sub.1 -C.sub.4)alkyl, said phenyl or (C.sub.1 -C.sub.4)alkyl each optionally substituted with one to three fluoro. 34. A compound of claim 33 wherein R.sup.1 is phenyl or thienyl, said phenyl or thienyl each optionally substituted with one to three fluoro or with one OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9. ##STR29## 35. A compound of claim 1 wherein said compound is of formula (II): ##STR30## 36. A compound of claim 35 wherein: A.sup.1 is hydroxy, (C.sub.1 -C.sub.4)alkoxy, or (C.sub.1 -C.sub.4)alkanoyloxy; A.sup.2, A.sup.3, and A.sup.4 are hydrogen; p is 0 or 1; R.sup.1 is (C.sub.1 -C.sub.4)alkyl, (C.sub.4 -C.sub.7)cycloalkyl, adamantyl, phenyl, pyridyl, or thienyl, wherein each of said phenyl, pyridyl, thienyl, or (C.sub.4 -C.sub.7)cycloalkyl groups is optionally substituted with one to three fluoro, or optionally substituted with one substituent selected from iodo, chloro, bromo, hydroxy, methoxy, dimethylamino, OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9, COOR.sup.7 or ethenyl-CONR.sup.4 R.sup.5 ; X is CH.sub.2, CH.sub.2 -phenylene, CO.sub.2, CO--(C.sub.0 -C.sub.2)alkylene, or SO.sub.2 --(C.sub.0 -C.sub.2)alkylene; R.sup.2 is (C.sub.1 -C.sub.7)alkyl, phenyl, benzyl, thienyl, (C.sub.5 -C.sub.7)cycloalkyl, isoxazolyl, tetrahydropyranyl, naphthyl, or benzodioxolyl, wherein said (C.sub.1 -C.sub.7)alkyl is optionally substituted with one to three fluoro, or optionally substituted with one to two substituents independently selected from amino and methylcarbonyl, and wherein each of said phenyl, thienyl, (C.sub.5 -C.sub.7)cycloalkyl, isoxazolyl, tetrahydropyranyl, naphthyl, and benzodioxolyl is optionally substituted with one to three fluoro, or optionally substituted with one to two substituents independently selected from hydroxy, methoxy, and (C.sub.1 -C.sub.3)alkyl; and R.sup.4 and R.sup.5 are each methyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached are pyrrolidino, piperidino, hexamethyleneimino, or morpholino. 37. A compound of claim 15 wherein said compound is of formula (II). 38. A compound of claim 37 if wherein said compound is 2,2,2-trifluoro-1-[7-hydroxy-4-(4-hydroxy-phenyl)-3,4-dihydro-1H-isoquinol in-2-yl]-ethanone, having the structure ##STR31## 39. A compound of the formula: ##STR32## wherein: A.sup.1 is hydrogen, hydroxy, (C.sub.1 -C.sub.4)alkoxy, or (C.sub.1 -C.sub.4)alkanoyloxy, said (C.sub.1 -C.sub.4)alkoxy or said (C.sub.1 -C.sub.4)alkanoyloxy being optionally substituted by hydroxy, halo, di(C.sub.1 -C.sub.4 alkyl)amino or a partially saturated, fully saturated, or fully unsaturated five to twelve membered ring optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; A.sup.2, A.sup.3, and A.sup.4 are independently selected from hydrogen, hydroxy, (C.sub.1 -C.sub.4)alkoxy, and halo; R.sup.1 is (C.sub.1 -C.sub.7)alkyl; adamantyl; a partially saturated, fully saturated, or fully unsaturated three to twelve membered ring optionally comprising one to four heteroatoms selected independently from oxygen, sulfur, and nitrogen; a bicyclic ring consisting of two fused independently partially saturated, fully saturated, or fully unsaturated five to six membered rings, said bicyclic ring optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; or a bicyclic ring system consisting of two rings joined by a covalent bond, said rings being independently partially saturated, fully saturated, or fully unsaturated three to eight membered rings, said bicyclic ring system optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; wherein each of the above R.sup.1 groups is optionally substituted with one to seven fluoro, or optionally substituted with one to three substituents independently selected from Group A, wherein Group A consists of hydroxy, chloro, bromo, iodo, (C.sub.1 -C.sup.4)alkyl, (C.sub.1 -C.sub.4)alkoxy, (C.sub.3 -C.sub.8)cycloalkyl, R.sup.3 --(C.sub.1 -C.sub.4)alkoxy, (C.sub.2 -C.sub.4)alkenyl-COOR.sup.7, (C.sub.0 -C.sub.4)alkyl-COOR.sup.7, (C.sub.1 -C.sub.4)alkanoyloxy-(C.sub.2 -C.sub.4)alkenyl, (C.sub.2 -C.sub.4)alkenyl-CONR.sup.4 R.sup.5, (C.sub.0 -C.sub.4)alkyl-CONR.sup.4 R.sup.5, (C.sub.0 -C.sub.4)alkyl-NR.sup.4 R.sup.5, OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9, propyl-R.sup.8 R.sup.9, and SO.sub.2 --R.sup.6 ; X is (C.sub.0 -C.sub.1)alkylene-phenylene-(C.sub.0 -C.sub.1)alkylene, CO.sub.2, CO, (C.sub.1 -C.sub.3)alkylene-CO--(C.sub.1 -C.sub.3)alkylene, (C.sub.0 -C.sub.3)alkylene-CO--(C.sub.2 -C.sub.3)alkylene, (C.sub.2 -C.sub.3)alkylene-CO--(C.sub.0 -C.sub.3)alkylene, or (C.sub.0 -C.sub.4)alkylene-SO.sub.2 --(C.sub.0 -C.sub.4)alkylene; R.sup.2 is (C.sub.1 -C.sub.9)alkyl; (C.sub.2 -C.sub.4)alkenyl; benzhydryl; a partially saturated, fully saturated, or fully unsaturated three to eight membered ring optionally comprising one to four heteroatoms selected independently from oxygen, sulfur, and nitrogen; a bicyclic ring consisting of two fused independently partially saturated, fully saturated, or fully unsaturated five to six membered rings, and said bicyclic ring optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; or a bicyclic ring system consisting of two rings joined by a covalent bond said rings being independently partially saturated, fully saturated, or fully unsaturated three to eight membered rings, and said bicyclic ring system optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; wherein said (C.sub.1 -C.sub.9)alkyl is optionally substituted with one to seven fluoro, or optionally substituted with one to three substituents independently selected from Group B, wherein Group B consists of chloro, (C.sub.1 -C.sub.4)alkoxy, amino, and (C.sub.1 -C.sub.4)alkylcarbonyl; wherein said (C.sub.2 -C.sub.4)alkenyl is optionally substituted with one to three substituents independently selected from Group C, wherein Group C consists of halo, (C.sub.1 -C.sub.4)alkoxy, amino, and (C.sub.1 -C.sub.4)alkylcarbonyl; and wherein said benzhydryl, said three to eight membered ring, said bicyclic ring, and said bicyclic ring system are each optionally substituted with one to three substituents independently selected from Group D, wherein Group D consists of halo, hydroxy, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4 alkoxy, imidazolyl, amino, (C.sub.1 -C.sub.4)alkylcarbonylamino, and (C.sub.1 -C.sub.4)alkylcarbonyl; R.sup.3 at each occurrence is independently pyrrolidino, piperidino, morpholino, or dimethylamino; R.sup.4 and R.sup.5 at each occurrence are independently hydrogen, (C.sub.1 -C.sub.4)alkyl, hydroxy(C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy-(C.sub.1 -C.sub.4)alkylene, or (C.sub.3 -C.sub.8)cycloalkyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached are pyrrolidino, piperidino, morpholino, or hexamethyleneimino; R.sup.6 at each occurrence is independently imidazolyl, thienyl, benzathienyl, or isoxazyl, each optionally substituted with one to three substituents independently selected from (C.sub.1 -C.sub.4)alkyl; R.sup.7 at each occurrence is independently hydrogen or (C.sub.1 -C.sub.4)alkyl; R.sup.8 and R.sup.9 are independently methyl or ethyl, or R.sup.8 and R.sup.9 taken together with the nitrogen atom to which they are attached are pyrrolidino, piperidino, morpholino, or hexamethyleneimino; and p is 0, 1, or 2. 40. A compound of the formula: ##STR33## wherein: A.sup.1 is hydrogen, hydroxy, (C.sub.1 -C.sub.4)alkoxy, or (C.sub.1 -C.sub.4)alkanoyloxy, said (C.sub.1 -C.sub.4)alkoxy or said (C.sub.1 -C.sub.4)alkanoyloxy being optionally substituted by hydroxy, halo, di(C.sub.1 -C.sub.4 alkyl)amino or a partially saturated, fully saturated, or fully unsaturated five to twelve membered ring optionally having up to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; A.sup.2, A.sup.3, and A.sup.4 are independently selected from hydrogen, hydroxy, (C.sub.1 -C.sub.4)alkoxy, and halo; R.sup.1 is (C.sub.1 -C.sub.7)alkyl; adamantyl; a partially saturated, fully saturated, or fully unsaturated three to twelve membered ring optionally comprising one to four heteroatoms selected independently from oxygen, sulfur, and nitrogen; a bicyclic ring consisting of two fused independently partially saturated, fully saturated, or fully unsaturated five to six membered rings, said bicyclic ring optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; or a bicyclic ring system consisting of two rings joined by a covalent bond, said rings being independently partially saturated, fully saturated, or fully unsaturated three to eight membered rings, said bicyclic ring system optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; wherein each of the above R.sup.1 groups is optionally substituted with one to seven fluoro, or optionally substituted with one to three substituents independently selected from Group A, wherein Group A consists of hydroxy, chloro, bromo, iodo, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy, (C.sub.3 -C.sub.8)cycloalkyl, R.sup.3 --(C.sub.1 -C.sub.4)alkoxy, (C.sub.2 -C.sub.4)alkenyl-COOR.sup.7, (C.sub.0 -C.sub.4)alkyl-COOR.sup.7, (C.sub.1 -C.sub.4)alkanoyloxy-(C.sub.2 -C.sub.4)alkenyl, (C.sub.2 -C.sub.4)alkenyl-CONR.sup.4 R.sup.5, (C.sub.0 -C.sub.4)alkyl-CONR.sup.4 R.sup.5, (C.sub.0 -C.sub.4)alkyl-NR.sup.4 R.sup.5, OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9, propyl-R.sup.8 R.sup.9 and SO.sub.2 --R.sup.6 ; X is a covalent bond, (CH.sub.2).sub.n wherein n is 1, 2, or 3, (C.sub.0 -C.sub.1)alkylene-phenylene-(C.sub.0 -C.sub.1)alkylene, CO.sub.2, (C.sub.0 -C.sub.3)alkylene-CO--(C.sub.0 -C.sub.3)alkylene, or (C.sub.0 -C.sub.4)alkylene-SO.sub.2 --(C.sub.0 -C.sub.4 alkylene; R.sup.2 is (C.sub.1 -C.sub.9)alkyl; (C.sub.2 -C.sub.4)alkenyl; benzhydryl; a partially saturated, fully saturated, or fully unsaturated four to five membered ring optionally comprising one to three heteroatoms selected independently from oxygen, sulfur, and nitrogen; a partially saturated, fully saturated, or fully unsaturated seven to eight membered ring optionally comprising one to four heteroatoms selected independently from oxygen, sulfur, and nitrogen; a bicyclic ring consisting of two fused independently partially saturated, fully saturated, or fully unsaturated five to six membered rings, said bicyclic ring optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; or a bicyclic ring system consisting of two rings joined by a covalent bond, said rings being independently partially saturated, fully saturated, or fully unsaturated three to eight membered rings, wherein said bicyclic ring system optionally comprises one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; wherein said (C.sub.1 -C.sub.9)alkyl is optionally substituted with one to seven fluoro, or optionally substituted with one to three substituents independently selected from Group B, wherein Group B consists of chloro, (C.sub.1 -C.sub.4)alkoxy, amino, and (C.sub.1 -C.sub.4)alkylcarbonyl; wherein said (C.sub.2 -C.sub.4)alkenyl is optionally substituted with one to three substituents independently selected from Group C, wherein Group C consists of halo, (C.sub.1 -C.sub.4)alkoxy, amino, and (C.sub.1 -C.sub.4)alkylcarbonyl; and wherein said benzhydryl, said four to five membered ring, said seven to eight membered ring, said bicyclic ring, and said bicyclic ring system are optionally substituted with one to three substituents independently selected from Group D, wherein Group D consists of halo, hydroxy, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy, imidazolyl, amino, (C.sub.1 -C.sub.4)alkylcarbonylamino, and (C.sub.1 -C.sub.4)alkylcarbonyl; R.sup.3 at each occurrence is independently pyrrolidino, piperidino, morpholino, or dimethylamino; R.sup.4 and R.sup.5 at each occurrence are independently hydrogen, (C.sub.1 -C.sub.4)alkyl, hydroxy(C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy-(C.sub.1 -C.sub.4)alkylene, or (C.sub.3 -C.sub.8)cycloalkyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached form pyrrolidino, piperidino, morpholino, or hexamethyleneimino; R.sup.6 at each occurrence is independently imidazolyl, thienyl, benzathienyl, or isoxazyl, said imidazolyl, thienyl, benzathienyl, or isoxazyl each optionally substituted with one to thee substituents independently selected from (C.sub.1 -C.sub.4)alkyl; R.sup.7 at each occurrence is independently hydrogen or (C.sub.1 -C.sub.4)alkyl; R.sup.8 and R.sup.9 at each occurrence are independently methyl or ethyl, or R.sup.8 and R.sup.9 taken together with the nitrogen atom to which they are attached are pyrrolidino, piperidino, morpholino, or hexamethyleneimino; and p is 0, 1, or 2; with the proviso that when X is (CH.sub.2).sub.2 or (CH.sub.2).sub.3, p is 0, and R.sup.1 is phenyl or phenyl substituted with a single chloro, fluoro, bromo, hydroxy, methoxy, pyrrolidinoethoxy, piperidinoethoxy or morpholinoethoxy substituent, then R.sup.2 is not tert-butyl or cyclopentyl. 41. A compound of claim 40 wherein: A.sup.1 is hydroxy; A.sup.2, A.sup.3, and A.sup.4 are hydrogen; and p is 0. 42. A compound of claim 41 wherein R.sup.1 is phenyl optionally substituted with one to three fluoro, or optionally substituted with one substituent selected from Group A. 43. A compound of claim 41 wherein R.sup.1 is phenyl substituted with one substituent selected from hydroxy, halo, piperidino-ethoxy, pyrrolidino-ethoxy, or morpholino-ethoxy. 44. A compound of claim 41 wherein R.sup.2 is (C.sub.1 -C.sub.7)alkyl; propenyl; a partially saturated, fully saturated, or fully unsaturated five membered ring optionally comprising one to two heteroatoms selected independently from oxygen, sulfur, and nitrogen; a bicyclic ring consisting of two fused independently partially saturated, fully saturated, or fully unsaturated five to six membered rings, wherein said bicyclic ring optionally comprises one to two oxygen atoms; or biphenyl; wherein said (C.sub.1 -C.sub.7)alkyl is optionally substituted with one to seven fluoro, or optionally substituted with one to three substituents independently selected from Group B; wherein said propenyl is optionally substituted with one to three substituents independently selected from Group C; and wherein each of said five membered ring, said bicyclic ring, and said biphenyl is optionally substituted with one to three substituents independently selected from Group D. 45. A compound of claim 44 wherein R.sup.2 is trifluoromethyl. 46. A compound of claim 41 wherein X is a covalent bond, CH.sub.2, CH.sub.2 -phenylene, CO.sub.2, CO--(C.sub.0 -C.sub.2)alkylene, or SO.sub.2 --(C.sub.0 -C.sub.2)alkylene. 47. A compound of claim 46 wherein X is CO or SO.sub.2. 48. A compound of the formula: ##STR34## wherein: A.sup.1 is hydrogen, hydroxy, (C.sub.1 -C.sub.4)alkoxy, or (C.sub.1 -C.sub.4)alkanoyloxy, said (C.sub.1 -C.sub.4)alkoxy or said (C.sub.1 -C.sub.4)alkanoyloxy optionally substituted by hydroxy, halo, di(C.sub.1 -C.sub.4 alkyl)amino or a partially saturated, fully saturated, or fully unsaturated five to twelve membered ring optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; A.sup.2, A.sup.3, and A.sup.4 are independently selected from hydrogen, hydroxy, (C.sub.1 -C.sub.4)alkoxy, and halo; R.sup.1 is (C.sub.1 -C.sub.7)alkyl; adamantyl; a partially saturated, fully saturated, or fully unsaturated three to twelve membered ring optionally comprising one to four heteroatoms selected independently from oxygen, sulfur, and nitrogen; a bicyclic ring consisting of two fused independently partially saturated, fully saturated, or fully unsaturated five to six membered rings, said bicyclic ring optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; or a bicyclic ring system consisting of two rings joined by a covalent bond, said rings being independently partially saturated, fully saturated, or fully unsaturated three to eight membered rings, said bicyclic ring system optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; wherein each of the above R.sup.1 groups is optionally substituted with one to seven fluoro, or optionally substituted with one to three substituents independently selected from Group A, wherein Group A consists of hydroxy, chloro, bromo, iodo, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy, (C.sub.3 -C.sub.8)cycloalkyl, R.sup.3 --(C.sub.1 -C.sub.4)alkoxy, (C.sub.2 -C.sub.4)alkenyl-COOR.sup.7, (C.sub.0 -C.sub.4 alkyl-COOR.sup.7, (C.sub.1 -C.sub.4)alkanoyloxy-(C.sub.2 -C.sub.4)alkenyl, (C.sub.2 -C.sub.4)alkenyl-CONR.sup.4 R.sup.5, (C.sub.0 -C.sub.4)alkyl-CONR.sup.4 R.sup.5, (C.sub.0 -C.sub.4)alkyl-NR.sup.4 R.sup.5, OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9, propyl-R.sup.8 R.sup.9 and SO.sub.2 --R.sup.6 ; X is a covalent bond, (CH.sub.2).sub.n where n is 1, 2, or 3, (C.sub.0 -C.sub.1)alkylene-phenylene-(C.sub.0 -C.sub.1)alkylene, CO.sub.2, (C.sub.0 -C.sub.3)alkylene-CO--(C.sub.0 -C.sub.3)alkylene, or (C.sub.0 -C.sub.4)alkylene-SO.sub.2 --(C.sub.0 -C.sub.4)alkylene; R.sup.2 is a partially saturated or fully saturated six membered ring optionally comprising one to three heteroatoms selected independently from oxygen, sulfur, and nitrogen; wherein said six membered ring is optionally substituted with one to three substituents independently selected from Group D, wherein Group D consists of halo, hydroxy, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy, imidazolyl, amino, (C.sub.1 -C.sub.4)alkylcarbonylamino, and (C.sub.1 -C.sub.4)alkylcarbonyl; R.sup.3 at each occurrence is independently pyrrolidino, piperidino, morpholino, or dimethylamino; R.sup.4 and R.sup.5 at each occurrence are independently hydrogen, (C.sub.1 -C.sub.4)alkyl, hydroxy(C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy-(C.sub.1 -C.sub.4)alkylene, or (C.sub.3 -C.sub.8)cycloalkyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached form pyrrolidino, piperidino, morpholino, or hexamethyleneimino; R.sup.6 at each occurrence is independently imidazolyl, thienyl, benzathienyl, or isoxazyl, each optionally substituted with one to three substituents independently selected from (C.sub.1 -C.sub.4)alkyl; R.sup.7 at each occurrence is independently hydrogen or (C.sub.1 -C.sub.4)alkyl; R.sup.8 and R.sup.9 at each occurrence are independently methyl or ethyl, or R.sup.8 and R.sup.9 taken together with the nitrogen atom to which they are attached form pyrrolidino, piperidino, morpholino, or hexamethyleneimino; and p is 0, 1, or 2. 49. A compound of the formula: ##STR35## wherein: A.sup.1 is hydrogen, hydroxy, (C.sub.1 -C.sub.4)alkoxy, or (C.sub.1 -C.sub.4)alkanoyloxy, said (C.sub.1 -C.sub.4)alkoxy or said (C.sub.1 -C.sub.4)alkanoyloxy being optionally substituted by hydroxy, halo, di(C.sub.1 -C.sub.4 alkyl)amino or a partially saturated, fully saturated, or fully unsaturated five to twelve membered ring optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; A.sup.2, A.sup.3, and A.sup.4 are independently selected from hydrogen, hydroxy, (C.sub.1 -C.sub.4)alkoxy, and halo; R.sup.1 is (C.sub.1 -C.sub.7)alkyl; adamantyl; a partially saturated, fully saturated, or fully unsaturated three to twelve membered ring optionally comprising one to four heteroatoms selected independently from oxygen, sulfur, and nitrogen; a bicyclic ring consisting of two fused independently partially saturated, fully saturated, or fully unsaturated five to six membered rings, said bicyclic ring optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; or a bicyclic ring system consisting of two rings joined by a covalent bond, said rings being independently partially saturated, fully saturated, or fully unsaturated three to eight membered rings, said bicyclic ring system optionally comprising one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; wherein each of the above R.sup.1 groups is optionally substituted with one to seven fluoro, or optionally substituted with one to three substituents independently selected from Group A, wherein Group A consists of hydroxy, chloro, bromo, iodo, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy, (C.sub.3 -C.sub.8)cycloalkyl, R.sup.3 --(C.sub.1 -C.sub.4)alkoxy, (C.sub.2 -C.sub.4)alkenyl-COOR.sup.7, (C.sub.0 -C.sub.4)alkyl-COOR.sup.7, (C.sub.1 -C.sub.4)alkanoyloxy-(C.sub.2 -C.sub.4)alkenyl, (C.sub.2 -C.sub.4)alkenyl-CONR.sup.4 R.sup.5, (C.sub.0 -C.sub.4)alkyl-CONR.sup.4 R.sup.5, (C.sub.0 -C.sub.4)alkyl-NR.sup.4 R.sup.5, OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9, propyl-R.sup.8 R.sup.9 and SO.sub.2 --R.sup.6 ; X is a covalent bond, (CH.sub.2).sub.n where n is 1, 2, or 3, (C.sub.0 -C.sub.1)alkylene-phenylene-(C.sub.0 -C.sub.1)alkylene, CO.sub.2, (C.sub.0 -C.sub.3)alkylene-CO--(C.sub.0 -C.sub.3)alkylene, or (C.sub.0 -C.sub.4)alkylene-SO.sub.2 --(C.sub.0 -C.sub.4)alkylene; R.sup.2 is (C.sub.1 -C.sub.9)alkyl; (C.sub.2 -C.sub.4)alkenyl; benzhydryl; a partially saturated, fully saturated, or fully unsaturated three to eight membered ring optionally comprising one to four heteroatoms selected independently from oxygen, sulfur, and nitrogen; a bicyclic ring consisting of two fused independently partially saturated, fully saturated, or fully unsaturated five to six membered rings, wherein said bicyclic ring optionally comprises one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; or a bicyclic ring system consisting of two rings joined by a covalent bond, said rings being independently partially saturated, fully saturated, or fully unsaturated three to eight membered rings, wherein said bicyclic ring system optionally comprises one to four heteroatoms independently selected from oxygen, sulfur, and nitrogen; wherein said (C.sub.1 -C.sub.9)alkyl is optionally substituted with one to seven fluoro, or optionally substituted with one to three substituents independently selected from Group B, wherein Group B consists of chloro, (C.sub.1 -C.sub.4)alkoxy, amino, and (C.sub.1 -C.sub.4)alkylcarbonyl; wherein said (C.sub.2 -C.sub.4)alkenyl is optionally substituted with one to three substituents independently selected from Group C, wherein Group C consists of halo, (C.sub.1 -C.sub.4)alkoxy, amino, and (C.sub.1 -C.sub.4)alkylcarbonyl; and wherein said benzhydryl, said three to eight membered ring, said bicyclic ring, and said bicyclic ring system is optionally substituted with one to three substituents independently selected from Group D, wherein Group D consists of halo, hydroxy, (C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy, imidazolyl, amino, (C.sub.1 -C.sub.4)alkylcarbonylamino, and (C.sub.1 -C.sub.4)alkylcarbonyl; R.sup.3 at each occurrence is independently pyrrolidino, piperidino, morpholino, or dimethylamino; R.sup.4 and R.sup.5 at each occurrence are independently hydrogen, (C.sub.1 -C.sub.4)alkyl, hydroxy(C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)alkoxy-(C.sub.1 -C.sub.4)alkylene, or (C.sub.3 -C.sub.8)cycloalkyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached form pyrrolidino, piperidino, morpholino, or hexamethyleneimino; R.sup.6 at each occurrence is independently imidazolyl, thienyl, benzathienyl, or isoxazyl, each optionally substituted with one to three substituents independently selected from (C.sub.1 -C.sub.4)alkyl; R.sup.7 at each occurrence is independently hydrogen or (C.sub.1 -C.sub.4)alkyl; R.sup.8 and R.sup.9 at each occurrence are independently methyl or ethyl, or R.sup.8 and R.sup.9 taken together with the nitrogen atom to which they are attached form pyrrolidino, piperidino, morpholino, or hexamethyleneimino; and p is 0,1, or 2. 50. A compound of claim 49 wherein: A.sup.1 is hydroxy, (C.sub.1 -C.sub.4)alkoxy, or (C.sub.1 -C.sub.4)alkanoyloxy; A.sup.2, A.sup.3, and A.sup.4 are hydrogen; p is 0 or 1; R.sup.1 is (C.sub.1 -C.sub.4)alkyl, (C.sub.4 -C.sub.7)cycloalkyl, adamantyl, phenyl, pyridyl, or thienyl, wherein each of said phenyl, pyridyl, thienyl, or (C.sub.5 -C.sub.7)cycloalkyl groups is optionally substituted with one to three fluoro, or optionally substituted with one substituent selected from iodo, chloro, bromo, hydroxy, methoxy, dimethylamino, OCH.sub.2 CH.sub.2 NR.sup.8 R.sup.9, COOR.sup.7, or ethenyl-CONR.sup.4 R.sup.5 wherein R.sup.4 and R.sup.5 are both methyl, or R.sup.4 and R.sup.5 taken together with the nitrogen atom to which they are attached form pyrrolidino, piperidino, hexamethyleneimino, or morpholino; X is CH.sub.2, CH.sub.2 -phenylene, CO.sub.2, CO--(C.sub.0 -C.sub.2)alkylene, or SO.sub.2 --(C.sub.0 -C.sub.2)alkylene; and R.sup.2 is (C.sub.1 -C.sub.7)alkyl, phenyl, benzyl, thienyl, (C.sub.5 -C.sub.7)cycloalkyl, isoxazolyl, tetrahydropyranyl, naphthyl, or benzodioxolyl, wherein said (C.sub.1 -C.sub.7)alkyl is optionally substituted with one to three fluoro, or optionally substituted with one to two substituents independently selected from amino and methylcarbonyl, and wherein each of said phenyl, thienyl, cyclohexyl, isoxazolyl, tetrahydropyranyl, naphthyl, and benzodioxolyl is optionally substituted with one to three fluoro, or optionally substituted with one to two substituents independently selected from hydroxy, methoxy, and (C.sub.1 -C.sub.3)alkyl. 51. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable vehicle, carrier, or diluent. 52. A pharmaceutical composition comprising a compound of claim 39 and a pharmaceutically acceptable vehicle, carrier, or diluent. 53. A pharmaceutical composition comprising a compound of claim 40 and a pharmaceutically acceptable vehicle, carrier, or diluent. 54. A pharmaceutical composition comprising: a compound of claim 1; an anabolic agent, a prodrug thereof, or a pharmaceutically acceptable salt of said anabolic agent or a said prodrug; and a pharmaceutically acceptable vehicle, carrier, or diluent. 55. A pharmaceutical composition comprising: a compound of claim 1; growth hormone, a growth hormone secretagogue, a prodrug thereof, or a pharmaceutically acceptable salt of said growth hormone secretagogue or a said prodrug; and a pharmaceutically acceptable vehicle, carrier, or diluent. 56. A pharmaceutical composition comprising: a compound of claim 1; a prostaglandin agonist/antagonist, a prodrug thereof, or a pharmaceutically acceptable salt of said prostaglandin agonist/antagonist or a said prodrug; and a pharmaceutically acceptable vehicle, carrier, or diluent. 57. A pharmaceutical composition comprising: a compound of claim 1; parathyroid hormone or sodium fluoride; and a pharmaceutically acceptable vehicle, carrier, or diluent.

Details for Patent 6,608,203

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2019-12-24